Literature DB >> 1895149

Cardiovascular reflexes and autonomic dysfunction in Parkinson's disease.

G Meco1, L Pratesi, V Bonifati.   

Abstract

Cardiovascular reflexes were analysed in a group of 20 patients suffering from Parkinson's disease and in 12 age-matched healthy subjects, in order to ascertain the incidence and degree of autonomic dysfunction. The following were measured: heart rate variation during normal breathing, postural change (30/15 ratio) and during the Valsalva manoeuvre: blood pressure variation after standing. These measurements were taken at least 12 h after therapy had been withdrawn and were repeated after therapy had been resumed. Significant changes in the different heart rate variation indices were found in the parkinsonian patients which correlated with the duration and severity of the extrapyramidal symptomatology. After standing the patients showed a significant drop in blood pressure, when compared respectively with their base values and with the response in controls. Anticholinergic drugs had no significant effect on the heart rate variation indices, whereas antiparkinsonian therapy seems to have contributed to the drop in blood pressure after standing.

Entities:  

Mesh:

Year:  1991        PMID: 1895149     DOI: 10.1007/bf00314779

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  Autonomic deficits in Parkinson's syndrome.

Authors:  O Appenzeller; J E Goss
Journal:  Arch Neurol       Date:  1971-01

2.  Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications.

Authors:  D J Ewing; I W Campbell; B F Clarke
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

3.  Ultrastructure of Lewy bodies in the stellate ganglion.

Authors:  L S Forno; R L Norville
Journal:  Acta Neuropathol       Date:  1976-03-30       Impact factor: 17.088

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 5.  [The neuropathology of Parkinson syndrome].

Authors:  F Gray
Journal:  Rev Neurol (Paris)       Date:  1988       Impact factor: 2.607

6.  Parkinson's disease and hypertension: chronic bromocriptine treatment.

Authors:  J L Montastruc; B Chamontin; A Rascol
Journal:  Neurology       Date:  1985-11       Impact factor: 9.910

7.  Cardiac denervation in diabetes.

Authors:  T Wheeler; P J Watkins
Journal:  Br Med J       Date:  1973-12-08

8.  Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition.

Authors:  C Sachs; B Berglund; L Kaijser
Journal:  Acta Neurol Scand       Date:  1985-01       Impact factor: 3.209

9.  The hypothalamus in Parkinson disease.

Authors:  J W Langston; L S Forno
Journal:  Ann Neurol       Date:  1978-02       Impact factor: 10.422

10.  Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes.

Authors:  M Kalia; K Fuxe; M Goldstein
Journal:  J Comp Neurol       Date:  1985-03-15       Impact factor: 3.215

View more
  18 in total

1.  Suppressed sympathetic skin response in Parkinson disease.

Authors:  T H Haapaniemi; J T Korpelainen; U Tolonen; K Suominen; K A Sotaniemi; V V Myllylä
Journal:  Clin Auton Res       Date:  2000-12       Impact factor: 4.435

2.  Cardiovascular variability in Parkinson's disease and extrapyramidal motor slowing.

Authors:  Rachael Brown; Stephen Duma; Olivier Piguet; G Anthony Broe; Vaughan G Macefield
Journal:  Clin Auton Res       Date:  2012-04-25       Impact factor: 4.435

3.  Gastric emptying, postprandial blood pressure, glycaemia and splanchnic flow in Parkinson's disease.

Authors:  Laurence G Trahair; Thomas E Kimber; Katerina Flabouris; Michael Horowitz; Karen L Jones
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

4.  Autonomic Nervous System Dysfunction in Parkinson's Disease.

Authors:  Theresa A. Zesiewicz; Matthew J. Baker; Mervat Wahba; Robert A. Hauser
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

5.  Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life.

Authors:  Christiane Magerkurth; Rita Schnitzer; Stefan Braune
Journal:  Clin Auton Res       Date:  2005-04       Impact factor: 4.435

6.  The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses.

Authors:  A Mesec; S Sega; T Kiauta
Journal:  Clin Auton Res       Date:  1993-10       Impact factor: 4.435

7.  Prevalence of orthostatic hypotension in Parkinson's disease.

Authors:  J M Senard; S Raï; M Lapeyre-Mestre; C Brefel; O Rascol; A Rascol; J L Montastruc
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

8.  Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.

Authors:  Kelly Claire Simon; Honglei Chen; Michael Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2007-08-29       Impact factor: 9.910

9.  Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline.

Authors:  Zaid A Abassi; Ofer Binah; Moussa B H Youdim
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

10.  Age and duration related changes in muscle sympathetic nerve activity in Parkinson's disease.

Authors:  K Shindo; H Watanabe; H Tanaka; K Ohashi; T Nagasaka; S Tsunoda; Z Shiozawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.